Compositions and methods for treating cancer using RHOA dominant negative forms
Abstract:
The present invention provides compositions and methods for treating cancers with reduced or absent CDH1 using a RHOA dominant negative polypeptide or biologically active fragment thereof, and/or a nucleic acid encoding a RHOA dominant negative polypeptide or biologically active fragment thereof.
Information query
Patent Agency Ranking
0/0